نتایج جستجو برای: hla class ii

تعداد نتایج: 963400  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Jörn Dengjel Maria-Dorothea Nastke Cécile Gouttefangeas Gitsios Gitsioudis Oliver Schoor Florian Altenberend Margret Müller Björn Krämer Anna Missiou Martina Sauter Jörg Hennenlotter Dorothee Wernet Arnulf Stenzl Hans-Georg Rammensee Karin Klingel Stefan Stevanović

PURPOSE To elicit a long-lasting antitumor immune response, CD8+ and CD4+ T cells should be activated. We attempted to isolate HLA-DR-presented peptides directly from dissected solid tumors, in particular from renal cell carcinoma, to identify MHC class II ligands from tumor-associated antigens (TAA) for their use in peptide-based immunotherapy. EXPERIMENTAL DESIGN Tumor specimens were analyz...

2011
Bart O. Roep Jan W. Drijfhout Luisa Mearin Yvonne Kooy-Winkelaar Menno van Lummel Antonis K. Moustakas Joachim Schweizer M. Luisa Mearin Chris J. Mulder George K. Papadopoulos Jeroen van Bergen Frits Koning

Journal: :Cancer research 2003
Aude Bonehill Carlo Heirman Sandra Tuyaerts Annelies Michiels Yi Zhang Pierre van der Bruggen Kris Thielemans

For the induction of an optimal immune response against cancer or infections not only CD8(+) CTLs but also CD4(+) T helper cells must be induced, in particular IFN-gamma-secreting type 1 T helper cells. Several strategies have been explored to target tumor-associated antigens to the HLA class II processing compartments. We engineered a genetic construct encoding an invariant chain (Ii) protein ...

2016
K. Jones L. Wockner R. M. Brennan C. Keane P. K. Chattopadhyay M. Roederer D. A. Price D. K. Cole B. Hassan K. Beck D. Gottlieb D. S. Ritchie J. F. Seymour F. Vari P. Crooks S. R. Burrows M. K. Gandhi

In 40% of cases of classical Hodgkin lymphoma (cHL), Epstein-Barr virus (EBV) latency-II antigens [EBV nuclear antigen 1 (EBNA1)/latent membrane protein (LMP)1/LMP2A] are present (EBV(+) cHL) in the malignant cells and antigen presentation is intact. Previous studies have shown consistently that HLA-A*02 is protective in EBV(+) cHL, yet its role in disease pathogenesis is unknown. To explore th...

Journal: :Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999
H Zhang A T Shepherd D D Eason S Wei J I Diaz J Y Djeu G D Wu G Blanck

Tumor cell lines with a defective retinoblastoma gene are unable to transcribe the HLA class II genes in response to IFN-gamma treatment, and reconstitution of functional Rb rescues IFN-gamma-induced class II gene expression. However, the molecular mechanism of Rb rescue of the class II genes is unknown. We have examined the effect of Rb expression on the activation of the promoter for HLA-DRA,...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1983
A Zeevi C Scheffel K Annen R J Duquesnoy

We have generated two alloreactive T-lymphocyte clones that recognize the products of the HLA-B locus. The primed lymphocyte testing (PLT) reactivity of clone HJ21 was monospecific for the HLA-B antigen Bw49, a subtype specificity of HLA-Bw21. The PLT specificity of clone RD3 was strongly associated with HLA-Bw21. Several monoclonal antibodies against class I HLA molecules inhibited the PLT res...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2003
Maaike E Ressing Daphne van Leeuwen Frank A W Verreck Raquel Gomez Bianca Heemskerk Mireille Toebes Maureen M Mullen Theodore S Jardetzky Richard Longnecker Marco W Schilham Tom H M Ottenhoff Jacques Neefjes Ton N Schumacher Lindsey M Hutt-Fletcher Emmanuel J H J Wiertz

Epstein-Barr virus (EBV) persists lifelong in infected hosts despite the presence of antiviral immunity. Many viral antigens are expressed during lytic infection. Thus, for EBV to spread, it must have evolved effective ways to evade immune recognition. Here, we report that HLA class II-restricted antigen presentation to T helper cells is hampered in the presence of the lytic-phase protein gp42....

Journal: :Archives of disease in childhood 1994
G Horneff R C Seitz V Stephan V Wahn

A 3 year old Turkish girl is described who was suffering from major histocompatibility complex (MHC) class II deficiency syndrome, which is characterised by the lack of expression of HLA class II antigens on mononuclear cells. The presence of HLA class II genes was demonstrable at the DNA level. Combined immunodeficiency was indicated by hypogammaglobulinaemia and the absence of delayed type hy...

Journal: :Journal of immunology 2006
Mireia Sospedra Paolo A Muraro Irena Stefanová Yingdong Zhao Katherine Chung Yili Li Marc Giulianotti Richard Simon Roy Mariuzza Clemencia Pinilla Roland Martin

The three HLA class II alleles of the DR2 haplotype, DRB1*1501, DRB5*0101, and DQB1*0602, are in strong linkage disequilibrium and confer most of the genetic risk to multiple sclerosis. Functional redundancy in Ag presentation by these class II molecules would allow recognition by a single TCR of identical peptides with the different restriction elements, facilitating T cell activation and prov...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید